# APC SPECIFIC MTOP INHIBITION POTENTIATES IMMUNE RESPONSE TO IIV IN ELDERLY RECIPIENTS.

> **NIH NIH N43** · QRONO, INC · 2022 · $597,598

## Abstract

The contract supports the development of a vaccine adjuvant.  The adjuvant development activities will occur within the context of an influenza vaccine.

## Key facts

- **NIH application ID:** 10688743
- **Project number:** 75N93022C00006-0-9999-1
- **Recipient organization:** QRONO, INC
- **Principal Investigator:** SAM ROTHSTEIN
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $597,598
- **Award type:** —
- **Project period:** 2022-01-10 → 2024-01-09

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10688743

## Citation

> US National Institutes of Health, RePORTER application 10688743, APC SPECIFIC MTOP INHIBITION POTENTIATES IMMUNE RESPONSE TO IIV IN ELDERLY RECIPIENTS. (75N93022C00006-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10688743. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*